Cell & Gene Therapy - In Vivo Base Editing Marks New Era in Personalized Genetic Medicine
View as a Web Page
News Medical
 
  Cell & Gene Therapy Cell & Gene Therapy logo  
  The latest stem cells news from News Medical  
 

CytoPak Bag Solution for Closed SystemsCytoPak Bag Solution for Closed Systems

Cytopak is ACROBiosystems’ flexible, closed-system solution designed to simplify the delivery of GMP-grade products for cell therapy manufacturing. Each single-use bag is preassembled with weldable tubing, allowing easy integration into closed or automated production workflows. The Cytopak lineup includes key products such as IL-2, IL-7, IL-15, DLL4 beads, and more. ACROBiosystems also offer Cytopak Custom GMP Bags to support the evolving needs of your manufacturing process.

Get Your GMP Free Sample Today!
 
   In Vivo Base Editing Marks New Era in Personalized Genetic MedicineIn Vivo Base Editing Marks New Era in Personalized Genetic Medicine
 
In vivo base editing enables precise, single-nucleotide changes to DNA without double-strand breaks. A recent application in CPS1 deficiency shows promise for personalized treatments in rare genetic disorders.
 
   Evidence for Neural Stem Cell-Based Therapies in Multiple SclerosisEvidence for Neural Stem Cell-Based Therapies in Multiple Sclerosis
 
Research indicates that neural stem cell transplants could promote myelin repair in progressive multiple sclerosis, paving the way for innovative treatments.
 
 New Study Reveals Varied CAR T-Cell Therapy Benefits in Large B-Cell Lymphoma
 
New Study Reveals Varied CAR T-Cell Therapy Benefits in Large B-Cell LymphomaA study identifies three patient subgroups in large B-cell lymphoma, revealing distinct responses to CD19 CAR T cell therapy and enhancing precision medicine.
 
 
 Aligned Stem Cell Sheets Show Boosted Healing Potential
 
Aligned Stem Cell Sheets Show Boosted Healing PotentialA new way to grow stem cells may help them release more of the signaling proteins they use to repair tissue, potentially improving future treatments.
 
 
 Gene therapy shows long-term success in hemophilia B patients
 
Gene therapy shows long-term success in hemophilia B patientsA gene transfer approach to treating the bleeding disorder hemophilia B remains safe and effective long-term, as scientists from St. Jude Children's Research Hospital and University College London today report thirteen years of follow-up data.
 
 
 CAR T-cell therapy successfully treats rare autoimmune disease of the peripheral nervous system
 
CAR T-cell therapy successfully treats rare autoimmune disease of the peripheral nervous systemPhysicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.
 
 
 Autophagy boosts precision in gene editing
 
Autophagy boosts precision in gene editingPrecision gene editing is crucial for treating genetic diseases, as it enables targeted correction of specific mutations.
 
 

How would you rate today's newsletter?

 
             
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025